Want to see ARZGY full AI Analyst Report?
Assicurazioni Generali (ARZGY) AI Stock Analysis
Assicurazioni Generali
(Other OTC:ARZGY)
The score is driven primarily by solid financial performance with strong recent cash generation, and a notably positive earnings call featuring reiterated guidance and strong H1 growth alongside a robust Solvency II capital position. Valuation is supportive with a reasonable P/E and attractive dividend yield. Technicals are positive but tempered by overbought readings (RSI/Stoch), and financial risk is constrained by the sharp 2025 leverage increase and profitability/cash-flow variability.
Assicurazioni Generali (ARZGY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $71.49B
- Dividend Yield
- 4.03%
- Average Volume (3M)
- 60.44K
- Price to Earnings (P/E)
- 14.2
- Beta (1Y)
- 0.40
- Revenue Growth
- -1.34%
- EPS Growth
- 30.09%
- Country
- US
- Employees
- 88,249
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Diversified
Assicurazioni Generali Business Overview & Revenue Model
Company Description
Assicurazioni Generali S.p.A. is a prominent financial services group that delivers a comprehensive array of insurance and investment solutions. The company's operations are distinctly categorized into four primary divisions: Non-Life, Life, Asset Ma...
How the Company Makes Money
Generali makes money mainly through its insurance operations and its asset/wealth management activities. In insurance, it earns (1) premium income from policyholders in life and P&C products. For P&C (e.g., motor, property, liability), profitability...
Assicurazioni Generali Earnings Call Summary
The call presents strong financial and operational performance across key metrics (revenue, operating result, adjusted net result, Life inflows and VNB), a very solid capital position (Solvency II 216%), high investment reinvestment yields and clear strategic growth initiatives (Redion, embedded insurance). Notable headwinds include elevated natural catastrophe and man‑made losses, modest combined‑ratio pressure, inflationary trends (especially in Germany non‑motor), some capital/SCR effects from growth and one‑off/seasonal volatility in China VNB. Management reiterated guidance, signalled confidence in overachieving EPS targets, and outlined disciplined capital deployment. Overall, positive results and strong strategic positioning outweigh the near‑term operational and market challenges.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Generali reiterated confident guidance built on strong H1 metrics: gross written premiums EUR 53.4bn (+5.8% y/y), operating result EUR 4.5bn (+11.2%), adjusted net result EUR 2.5bn (+13.7%) and adjusted EPS up ~14.3%, with a Solvency II ratio of 216% at Q2 despite a EUR 500m buyback and the end of subordinated-bond grandfathering. By business: Life operating result was EUR 2.2bn (+8.8%) with record net inflows >EUR 8.3bn, VNB EUR 1.89bn (+21.1%) and a new business margin of 5.86%; P&C operating result was >EUR 2.1bn (+4.7%) with a combined ratio of 91.5% (vs 91.0) and a 3.6pp Nat Cat impact (additional ~EUR 425m of Nat Cat/man‑made claims y/y; July prelim. Nat Cat ~EUR 300m and ~EUR 60m man‑made); Asset & Wealth Management operating result grew 31.3% and contributed ~16% of group operating result. Management kept investment-result guidance (P&C EUR 1.1bn, Life EUR 900m), noted reinvestment yields of ~4.24% (core Life) and ~4.01% (core P&C) versus maturing 2.37% (delta ~1.64%), said SAA optimization uses ~2pp of solvency per quarter, expects a +15pp Solvency II uplift from Jan 2027, sees RoRC accretion of ~+1.5pp, and reconfirmed targets while flagging net other non‑operating expenses EUR 200–300m (restructuring EUR 100–150m), nearly EUR 4.6bn cash remitted (~95% collected) and plans to reassess capital deployment at year‑end.
Assicurazioni Generali Financial Statement Overview
Summary
Solid profitability and improving scale with strong cash generation in 2024–2025 support the score. Offsetting this, leverage jumped in 2025 (debt-to-equity ~1.23 vs. ~0.58 in 2024) and both margins and cash flows have shown meaningful variability.
Income Statement
74PositiveBalance Sheet
66PositiveCash Flow
70Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.54B | 66.36B | 55.30B | 53.73B | 50.48B | 95.67B |
| Gross Profit | 45.29B | 66.36B | 55.30B | 48.48B | 16.42B | 95.67B |
| EBITDA | 7.81B | 6.90B | 7.19B | 112.77B | 5.65B | 6.09B |
| Net Income | 4.59B | 4.01B | 3.72B | 3.75B | 2.35B | 2.85B |
Balance Sheet | ||||||
| Total Assets | 580.95B | 558.29B | 538.65B | 508.61B | 519.05B | 586.23B |
| Cash, Cash Equivalents and Short-Term Investments | 7.04B | 7.30B | 246.29B | 230.43B | 287.67B | 357.05B |
| Total Debt | 41.47B | 39.55B | 17.58B | 33.17B | 16.48B | 16.57B |
| Total Liabilities | 546.08B | 523.52B | 505.55B | 477.33B | 500.91B | 554.35B |
| Stockholders Equity | 32.09B | 32.05B | 30.39B | 28.97B | 26.65B | 29.31B |
Cash Flow | ||||||
| Free Cash Flow | 22.80B | 18.69B | 16.41B | 1.55B | 9.90B | 29.39B |
| Operating Cash Flow | 23.16B | 19.12B | 16.82B | 1.73B | 10.54B | 17.48B |
| Investing Cash Flow | -21.63B | -18.25B | -15.12B | 2.28B | -9.02B | -16.30B |
| Financing Cash Flow | -2.45B | -1.76B | -369.94M | -3.80B | -2.42B | -677.00M |
Assicurazioni Generali Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARZGY, the sentiment is Negative. The current price of 23.70 is above the 20-day moving average (MA) of 23.65, below the 50-day MA of 24.73, and above the 200-day MA of 22.90, indicating a neutral trend. The MACD of -0.23 indicates Negative momentum. The RSI at 44.87 is Neutral, neither overbought nor oversold. The STOCH value of 29.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ARZGY.
Assicurazioni Generali Peers Comparison
Overall Rating
ACGL83Outperform
HIG81.7Outperform
BRK.B77Outperform
AEG74Outperform
ARZGY73Outperform
AIG65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | $36.29B | 8.59 | 18.35% | ― | -5.29% | 14.08% | |
| 82Outperform | $35.46B | 7.95 | 24.13% | 1.81% | 4.08% | 34.70% | |
| 77Outperform | $1.16T | 13.67 | 11.86% | ― | 3.93% | 36.30% | |
| 74Outperform | $12.41B | 11.38 | 12.23% | 5.93% | 24.97% | ― | |
| 73Outperform | $71.38B | 14.20 | 14.20% | 4.03% | -1.34% | 30.09% | |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 65Neutral | $42.82B | 14.86 | 7.27% | 2.32% | -4.19% | 1.09% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ARZGY | Assicurazioni Generali SpA | 23.70 | 4.54 | 23.69% | |
| AEG | Aegon Nv | 8.18 | 0.96 | 13.25% | |
| AIG | American International Group, Inc. | 81.90 | 4.84 | 6.28% | |
| ACGL | Arch Capital | 106.36 | 20.36 | 23.67% | |
| HIG | Hartford Insurance Group Inc | 132.59 | 10.51 | 8.61% | |
| BRK.B | Berkshire Hathaway B | 542.49 | 66.81 | 14.05% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 07, 2026